Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Clinical trial NCT06983210 · RECRUITING

Trial details

NCT number: NCT06983210
Sponsor: Nagoya University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma Bladder Urothelial Carcinoma of the Renal Pelvis and Ureter Urothelial Carcinoma Urethra Urothelial Carcinoma Recurrent

Start date: 2025-05-01
Primary completion: 2027-03-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.